Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer

Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer

Tumor angiogenesis research and antiangiogenic drug development make use of cultured endothelial cells (ECs) including the human microvascular ECs among others. However, it has been reported that tumor ECs (TECs) are different from normal ECs (NECs). To functionally validate antiangiogenic drugs, cu...

Full description

Bibliographic Details
Main Authors: Nako Maishi, Hiroshi Kikuchi, Masumi Sato, Hiroko Nagao-Kitamoto, Dorcas A. Annan, Shogo Baba, Takayuki Hojo, Misa Yanagiya, Yusuke Ohba, Genichiro Ishii, Kenkichi Masutomi, Nobuo Shinohara, Yasuhiro Hida, Kyoko Hida
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:International Journal of Molecular Sciences
Subjects:
immortalization
tumor endothelial cells
angiogenesis
renal carcinoma
Online Access:https://www.mdpi.com/1422-0067/20/18/4595

Internet

https://www.mdpi.com/1422-0067/20/18/4595

Similar Items